Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881304 · ClinicalTrials.gov registry record · NA
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
A NA study of Electronic Cigarette Use, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05881304 is a NA study of Electronic Cigarette Use that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 210-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05881304, a NA study of Electronic Cigarette Use, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to conduct a pilot randomized waitlist-controlled trial to assess the feasibility, acceptability, and preliminary effects of substituting the NIDA standardized research e-cigarette (SREC) for combusted cigarettes in MOUD-TUD who are not ready to quit smoking. A waitlist controlled RCT using a mixed-methods sequential explanatory design will investigate the impact of SREC provision on: 1) tobacco use behavior (e.g., cigarettes per day \[primary outcome\], SREC use), 2) biomarkers (e.g., carbon monoxide, anabasine), 3) cigarette dependence and withdrawal, and 4) short-term health effects and tolerability (e.g., respiratory symptoms, substance use). In the proposed RCT, N=40 adults stable on MOUD with buprenorphine who report daily smoking recruited from MGH primary care practices will be randomly assigned to receive the SREC for 8 weeks, either immediately (iSREC), or after an 8-week delay (waitlist control \[WLC\]). They will be followed an additional 4 weeks after SREC provision ends (to 12 weeks in iSREC and 20 weeks in WLC).
Conditions Studied
Interventions
- DEVICE Standardized research e-cigarette (SREC)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05881304
The ClinicalTrials.gov registry entry for NCT05881304 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (81% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 1 intervention - of which Standardized research e-cigarette (SREC) is the first listed.
NCT05881304 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05881304 about?
NCT05881304 is a clinical study titled "Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC". The goal of this study is to conduct a pilot randomized waitlist-controlled trial to assess the feasibility, acceptability, and preliminary effects of substituting the NIDA standardized research e-cigarette (SREC) for combusted cigarettes in MOUD-TUD who are not ready to quit smoking. A waitlist con...
What is the current status of trial NCT05881304?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-03. Estimated completion is 2026-06-01.
What conditions does trial NCT05881304 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT05881304?
The interventions under investigation include: Standardized research e-cigarette (SREC) (DEVICE).
Who is sponsoring clinical trial NCT05881304?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881304 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Social Media Use on Young Adults' E-Cigarette Use
RECRUITING · NA
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
Developing and Testing Health Warning Labels on the ENDS Device
RECRUITING · NA
-
Development of UP2UTobacco for High School Youth
ACTIVE NOT RECRUITING · NA
-
PACE Vape Messaging Study
COMPLETED · NA
-
Assessing Electronic Cigarette Nicotine Flux
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.